Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cliintel Capital is a venture capital firm founded in 2015 by Richard Michael Batenburg Jr. and Richard Michael Batenburg III. The firm is headquartered in Greenwood Village, Colorado, and focuses on equipping growth-oriented companies across the cannabis supply chain and other emerging vice industries with essential tools and support. The firm emphasizes a people-driven approach to investing, aiming to connect ideas, people, and resources to create value.
As of now, Cliintel Capital manages a portfolio of six companies and operates primarily in North America. The firm invests at various stages, including seed, Series A, and growth equity. Their notable milestones include establishing a strong presence in the cannabis sector and expanding their portfolio to include companies in healthcare and consumer markets.
Cliintel Capital primarily invests in the cannabis sector and other emerging vice industries. Their investment strategy includes providing funding and strategic consulting services to help companies navigate heavily regulated markets. The firm’s services encompass capital strategy, strategic partnerships, corporate governance compliance, investor relations, organizational structure, and business acumen.
Cliintel Capital seeks growth-oriented companies that demonstrate potential in the cannabis supply chain and other vice sectors. They look for founders who are innovative and capable of navigating complex regulatory environments. The firm’s deal structure preferences include a focus on providing not just capital but also strategic support to enhance the operational capabilities of their portfolio companies.
Cliintel Capital's portfolio includes six notable companies:
These companies reflect Cliintel Capital's focus on the cannabis sector and other emerging vice industries, showcasing their commitment to supporting growth-oriented businesses.
Richard M. Batenburg Jr. - Fund Manager. Richard has extensive experience in venture capital and has been instrumental in establishing Cliintel Capital's focus on the cannabis sector.
Rick Batenburg - Chief Investment Officer. Rick brings a wealth of knowledge in investment strategies and has led several successful funding rounds for portfolio companies.
Monica Pina - SVP, Investor Relations. Monica manages investor relations and is responsible for maintaining strong communication with stakeholders and potential investors.
Cliintel Capital prefers pitches to be submitted through their contact page at Cliintel Capital Contact. Founders should include a comprehensive deck that outlines their business model, market opportunity, and team qualifications. Response times may vary, but they encourage clear and concise communication.
As of October 2023, Cliintel Capital has been actively promoting its mission and portfolio through its website, emphasizing its focus on the cannabis industry and other vice sectors. The firm continues to expand its portfolio and strengthen its presence in the market.
Recent activities include updates on their notable portfolio companies and ongoing efforts to support growth-oriented businesses in heavily regulated markets.
What are Cliintel Capital's investment criteria?
Cliintel Capital invests in growth-oriented companies primarily within the cannabis sector and other emerging vice industries. They look for companies that can navigate heavily regulated markets and demonstrate strong potential for growth.
How can I apply or pitch to Cliintel Capital?
Founders can pitch to Cliintel Capital by visiting their contact page at Cliintel Capital Contact or by emailing Monica Pina at monica@cliintel.com. They encourage detailed presentations that outline the business model, market opportunity, and team capabilities.
What makes Cliintel Capital different from other venture firms?
Cliintel Capital emphasizes a people-driven approach, connecting ideas, people, and resources to create value. Their expertise in navigating complex regulatory environments in the cannabis sector sets them apart.
What is the geographic scope of Cliintel Capital's investments?
Cliintel Capital primarily focuses on investments in North America, particularly in the cannabis supply chain and other emerging vice industries.
What is the typical check size for investments?
While specific check sizes are not disclosed, Cliintel Capital invests at various stages, including seed, Series A, and growth equity, indicating a flexible approach to funding.
What kind of post-investment involvement can founders expect?
Cliintel Capital provides strategic consulting services post-investment, including support in capital strategy, corporate governance compliance, and organizational structure, ensuring that portfolio companies have the necessary tools for success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.